| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-09 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 9e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.0005 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |